Tris Pharma (Sales and Distribution Rights of Delsym) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Tris Pharma (Sales and Distribution Rights of Delsym) General Information

Description

A portfolio of sales and distribution rights. The asset covers United States store brand rights to sell and distribute Dextromehtorphan Polistirex Extended Release Suspension Cough Suppressant, the generic version of Reckitt Benckiser's Delsym.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Healthcare
Acquirer
Primary Office
  • 2031 US Highway 130
  • Monmouth Junction, NJ 08852
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tris Pharma (Sales and Distribution Rights of Delsym) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tris Pharma (Sales and Distribution Rights of Delsym)‘s full profile, request access.

Request a free trial

Tris Pharma (Sales and Distribution Rights of Delsym) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tris Pharma (Sales and Distribution Rights of Delsym)‘s full profile, request access.

Request a free trial